Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02397629 · ClinicalTrials.gov registry record
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 62
- Enrollment target
NCT02397629 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 62 participants.
The verdict
NCT02397629 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is a cross sectional study to examine the relationship between serum calcium and PTHrP and serum PSA in men referred for prostate biopsy at Wake Forest University.
Interventions
- OTHER This study has no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02397629
The ClinicalTrials.gov registry entry for NCT02397629 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which This study has no intervention is the first listed.
NCT02397629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02397629 about?
NCT02397629 is a clinical study titled "Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis". This is a cross sectional study to examine the relationship between serum calcium and PTHrP and serum PSA in men referred for prostate biopsy at Wake Forest University.
What is the current status of trial NCT02397629?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2013-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02397629?
The interventions under investigation include: This study has no intervention (OTHER).
Who is sponsoring clinical trial NCT02397629?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.